Regenerative Medicine as a Disrupter in Clinical Trials

PharmaTalkRadio

English - July 30, 2019 12:00 - 32 minutes - 28.6 MB - ★★★★ - 16 ratings
Science pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 6th Annual Mobile in Clinical Trials: What to Expect in 4 Minutes

Next Episode: How Digital Biomarker Innovation is Modernizing Clinical Endpoints

This is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical trials with the advancement of regenerative medicine, and how regenerative medicine can improve accuracy and speed up the clinical trial process.

Speaker:

Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine

The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.